Wong C, Dash A, Fredrickson J, Lewin-Koh N, et al. Fibroblast growth factor receptor 1/Klothobeta agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial. Hepatology 2023;78:847-862.
PMID: 35993161